Injective Launches Synthetic Assets on its Solstice Testnet

Injective Launches Synthetic Assets on its Solstice Testnet
Injective Launches Synthetic Assets on its Solstice Testnet

Today marks the launch of the very first synthetic commodity market on Injective.

Injective will tap into the rapidly growing synthetics market with the addition of gold on the Solstice testnet. Users can now trade gold perpetual markets with up to 20x leverage.

Injective has recently released a number of digital asset markets, which you can read more about here. Enabling the trading of gold demonstrates just how limitless and diverse markets on Injective can truly be. The price oracles utilized enable real-time feeds which further allows traders to trade gold 24/7 on Injective.

This new avenue begins with the introduction of gold as it is currently one of the most highly traded assets worldwide. There was also significant interest from the community to see synthetic commodities when they participated in a survey last month.

The community will continue to explore the addition of both new synthetic assets and new markets not available anywhere else. The goal of the Injective community is to facilitate trading for every single available market globally. This vision encompasses digital assets, synthetics, and much more! Community members will also be able to create and trade any market of their choice soon. This means Injective will quite literally offer unlimited options for markets to trade on without any form of restriction.

See you on Solstice.

About Injective

Injective is a custom interoperable layer one protocol for building powerful exchange, DeFi, derivatives & Web3 applications. Injective was created using the Cosmos SDK and is able to achieve instant transaction finality while sustaining lightning fast speeds. INJ is the native deflationary scarce asset that powers the Injective Protocol and its rapidly growing ecosystem. Injective is incubated by Binance and is backed by Pantera Capital.

Website | Telegram | Discord | Blog | Twitter | Learn | Youtube | Facebook | LinkedIn | Reddit | Instagram | Weibo | Orbit Newsletter